| SCIENTURE HLDGS INC. O.N. |
| USA |
| Gesundheit |
| US80880X1046 / A40QA7 |
| 4E4 (Frankfurt) / SCNX (NASDAQ) |
| FRA:4E4, ETR:4E4, 4E4:GR, NASDAQ:SCNX |
| - |
| https://scienture.com/ |
|
Scienture Holdings operates as a specialty pharmaceutical company through its wholly owned subsidiary Scienture, LLC, focusing on developing and commercializing branded pharmaceutical products for central nervous system and cardiovascular diseases in..
>Volltext.. |
| 10.43 Mio. EUR |
| 12.33 Mio. EUR |
| 0.57 Mio. EUR |
| -14.95 Mio. EUR |
| -17.81 Mio. EUR |
| -1.57 EUR |
| 2.21 Mio. EUR |
| 0.31 Mio. EUR |
| -9.63 Mio. EUR |
| 0.05 |
| -73.18% |
| 18.35% |
| - |
| - |
| - |
| - |
| SCIENTURE |
| 06.04.26 |
|